Version: 1.0.0 | Published: 7 Jan 2026 | Updated: 52 days ago
Documentation
Description:
WOP, open-label, multi-centre, phase IIa trial comprising multiple non-comparative treatment cohorts with patient allocation via minimisation or allocation according to HRD and germline BRCA1/2 mutation status.
The trial consists of two parts: a post-neoadjuvant treatment preoperative WOP component (PART 1); and a post-operative component (PART 2).
Collection of samples and clinical data.
Coverage
Spatial:
United Kingdom
Provenance
Origin
Purposes:
Trial
Temporal
Accrual Periodicity:
Static
Start Date:
01 January 2019
Time Lag:
Other
Accessibility
Access
Access Rights:
Please contact the publisher using Contact Point details provided
Access Request Cost:
Not specified
Delivery Lead Time:
Other
Jurisdictions:
UK
Data Controller:
The Institute of Cancer Research
Data Processor:
The Institute of Cancer Research
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en
Formats:
In Progress